SCNI

#5160
Scinai Immunotherapeutics Ltd. American Depositary Shares
0.6021 USD
+1.81%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
0.6021
0.6021
Faixa anual
0.5500
1.0499
Mudança diária
+1.81%
Mudança mensal
-15.32%
Mudança em 6 meses
-20.38%
Mudança anual
-20.38%
Fechamento anterior
0.5914
Abrir
0.6021
Bid
Ask
Mínimo
0.6021
High
0.6021
Volume
1
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 2.0882 M
  • Employee 31
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Technology
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

Notícias